Cargando…

Cisplatin decreases cyclin D2 expression via upregulating miR-93 to inhibit lung adenocarcinoma cell growth

MicroRNAs (miRNAs/miRs) serve important roles in the chemotherapeutic effect of anticancer drugs. To investigate the roles of miRNAs in cisplatin-induced suppression of lung adenocarcinoma cell proliferation, A549 cells were treated with different concentrations of cisplatin. An MTT assay demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Ning, Liu, Yuan-Rong, Li, Yan-Mei, Yang, Ya-Nan, Pan, Li, Wei, Yu-Bo, Wang, Ping-Yu, Li, You-Jie, Xie, Shu-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755153/ https://www.ncbi.nlm.nih.gov/pubmed/31432162 http://dx.doi.org/10.3892/mmr.2019.10566

Ejemplares similares

High glucose concentration induces endothelial cell proliferation by regulating cyclin‐D2‐related miR‐98
por: Li, Xin‐Xin, et al.
Publicado: (2016)

RUNX1 promote invasiveness in pancreatic ductal adenocarcinoma through regulating miR-93
por: Cheng, Yin, et al.
Publicado: (2017)

Induction of microRNA-let-7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1
por: Zhao, Wei, et al.
Publicado: (2018)

Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients
por: Barry, Simone E, et al.
Publicado: (2015)

LncRNAMORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93
por: Lv, Jing, et al.
Publicado: (2020)

Upregulation of Cyclin B1 by miRNA and its implications in cancer
por: Huang, Vera, et al.
Publicado: (2012)

MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma
por: Dong, Wei, et al.
Publicado: (2021)

LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p
por: Wei, Lei, et al.
Publicado: (2019)

miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin
por: You, Faping, et al.
Publicado: (2020)

MiR-93 enhances angiogenesis and metastasis by targeting LATS2
por: Fang, Ling, et al.
Publicado: (2012)

Dinitrosopiperazine‐decreased PKP3 through upregulating miR‐149 participates in nasopharyngeal carcinoma metastasis
por: Li, Yuejin, et al.
Publicado: (2018)

Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells
por: Gao, Shen-meng, et al.
Publicado: (2012)

miR-511 and miR-1297 Inhibit Human Lung Adenocarcinoma Cell Proliferation by Targeting Oncogene TRIB2
por: Zhang, Chao, et al.
Publicado: (2012)

LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 via miR-206
por: Hou, Hui, et al.
Publicado: (2021)

Downregulation of exosomal miR-1273a increases cisplatin resistance of non-small cell lung cancer by upregulating the expression of syndecan binding protein
por: Zhao, Xiaolong, et al.
Publicado: (2020)

miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer
por: Khan, Sonja, et al.
Publicado: (2013)

Exosomal miR-93-5p as an important driver of bladder cancer progression
por: Yuan, Feng, et al.
Publicado: (2023)

Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D
por: Munoz, Jessian L., et al.
Publicado: (2019)

miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells
por: Li, Jipeng, et al.
Publicado: (2014)

Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR‐1270 inhibition
por: Yuan, Wenbo, et al.
Publicado: (2019)

The Mechanism of miR-155/miR-15b Axis Contributed to Apoptosis of CD34+ Cells by Upregulation of PD-L1 in Myelodysplastic Syndromes
por: Cao, MeiWan, et al.
Publicado: (2023)

miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation
por: Zhang, Qian, et al.
Publicado: (2021)

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
por: Li, Hao-Yi, et al.
Publicado: (2017)

Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells
por: Zheng, Hong, et al.
Publicado: (2020)

Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy
por: Gong, Qiaoyun, et al.
Publicado: (2019)

miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma
por: Liang, Yicheng, et al.
Publicado: (2017)

miR-320a upregulation contributes to the development of preeclampsia by inhibiting the growth and invasion of trophoblast cells by targeting interleukin 4
por: Xie, Ning, et al.
Publicado: (2019)

circ-LIMK1 regulates cisplatin resistance in lung adenocarcinoma by targeting miR-512-5p/HMGA1 axis
por: Li, Ya, et al.
Publicado: (2022)

Upregulation of circulating miR130a is correlated with development of Barrett’s esophagus and esophageal adenocarcinoma
por: Wang, Li, et al.
Publicado: (2018)

Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma
por: Chen, Xiao-Yu, et al.
Publicado: (2018)

Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1
por: Duan, Peng-jing, et al.
Publicado: (2020)

The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma
por: Shen, Hongzhang, et al.
Publicado: (2021)

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
por: Li, Nana, et al.
Publicado: (2017)

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2
por: WANG, TAIREN, et al.
Publicado: (2015)

Downregulation of miR-193a-3p via targeting cyclin D1 in thyroid cancer
por: Li, Xiao-Jiao, et al.
Publicado: (2020)

Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p
por: Liu, Shicheng, et al.
Publicado: (2020)

circRNA_001275 upregulates Wnt7a expression by competitively sponging miR-370-3p to promote cisplatin resistance in esophageal cancer
por: Zou, Fang-Wen, et al.
Publicado: (2020)

circRNA_001275 upregulates Wnt7a expression by competitively sponging miR-370-3p to promote cisplatin resistance in esophageal cancer
por: Zou, Fang-Wen, et al.
Publicado: (2020)

Expression of miR-93-5p as a Potential Predictor of the Severity of Chronic Thromboembolic Pulmonary Hypertension
por: Gong, Juanni, et al.
Publicado: (2021)

miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
por: Li, Ye, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s16uvjersf0tjep6ct3d5rtm5f